1-5 of 5
Michael Trigg, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Secondary Chromosomal Abnormalities Appear to Be Less Prognostic for Children with Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Treated with Intensified Imatinib and Chemotherapy: Results of the Children's Oncology Group (COG) Study AALL0031.

Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Meenakshi Devidas, PhD, W. Paul Bowman, Chenguang Wang, Michael Trigg, MD, Bruce Camitta, MD, Paul S. Gaynon, MD, Naomi J. Winick, MD, Stephen P Hunger, MD, William L. Carroll, MD, Kirk R. Schultz, MD
Journal: Blood
Blood (2009) 114 (22): 2606.
https://doi.org/10.1182/blood.V114.22.2606.2606
Published: 2009
Journal Articles

Immunocompromised Status of Patients with Hematologic and Solid Tumor Malignancies: Construction of a Practical Algorithm.

Trung N Tran, M.D., Ph.D., G. Thomas Ray, Patricia Saddier, Michael Trigg, MD, Neil Hayes, Yan Li, MD, PhD, David A. Rizzieri, MD, Anthony Stein, David Weber, Jonathan Serody, Ralph Raasch, Laurel Habel
Journal: Blood
Blood (2009) 114 (22): 2484.
https://doi.org/10.1182/blood.V114.22.2484.2484
Published: 2009
Journal Articles

Philadelphia Chromosome Negative (Ph-) Very High Risk (VHR) Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents: The Impact of Intensified Chemotherapy on Early Event Free Survival (EFS) in Children’s Oncology Group (COG) Study AALL0031.

Kirk R. Schultz, MD, William Paul Bowman, William Slayton, MD, Alexander Aledo, MD, Meenakshi Devidas, PhD, Harland Sather, PhD, Michael J. Borowitz, MD, PhD, Stella M. Davies, MBBS, PhD, Michael Trigg, MD, Bernice Pasut, RN, Dean Jorstad, RPh, Tammie Eslinger, CCRP, Laura Burden, CCRP, Chenguang Wang, MS, Robert Rutledge, MD, Bruce Camitta, MD, Paul S. Gaynon, MD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Naomi Winick, MD, Stephen P. Hunger, MD, William L. Carroll, MD
Journal: Blood
Blood (2008) 112 (11): 911.
https://doi.org/10.1182/blood.V112.11.911.911
Published: 2008
Journal Articles

Improved Early Event Free Survival (EFS) in Children with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) with Intensive Imatinib in Combination with High Dose Chemotherapy: Children’s Oncology Group (COG) Study AALL0031.

Kirk R. Schultz, MD, W. Paul Bowman, MD, William Slayton, MD/PhD, Alex Aledo, MD, Meenakshi Devidas, PhD, Harland Sather, PhD, Michael J. Borowitz, MD/PhD, Stella M. Davies, MD/PhD, Michael Trigg, MD, Bernice Pasut, Dean Jorstad, Tammie Eslinger, Laura E. Burden, Chenguang Wang, PhD, Robert Rutledge, MD, Paul S. Gaynon, MD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Naomi Winick, MD, Stephen Hunger, MD/PhD, William L. Carroll, MD/PhD, Bruce Camitta, MD/PhD
Journal: Blood
Blood (2007) 110 (11): 4.
https://doi.org/10.1182/blood.V110.11.4.4
Published: 2007
Journal Articles

Obesity and Body Weight Independently Predict Relapse and Survival in Preadolescents and Teenagers with Acute Lymphoblastic Leukemia (ALL). A Retrospective Analysis of Five Children Cancer Group (CCG) Studies.

Anna Butturini, MD, Fred Dorey, PhD, Paul Gaynon, MD, Cecilia Fu, MD, Janet Franklin, MD, Stuart Siegel, MD, Nancy Sacks, RN, Nita Siebel, MD, David Henry, MD, Paul Rogers, MD, Beverly Lange, MD, Harland Sather, PhD, Michael Trigg, MD, Archie Bleyer, MD
Journal: Blood
Blood (2004) 104 (11): 992.
https://doi.org/10.1182/blood.V104.11.992.992
Published: 2004